Northern Trust’s Asterias Biotherapeutics Warrants AST.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-17,548
Closed -$9K – 4342
2017
Q2
$9K Hold
17,548
– – ﹤0.01% 4227
2017
Q1
$7K Sell
17,548
-4
-0% -$1 ﹤0.01% 4209
2016
Q4
$10K Buy
17,552
+4
+0% +$2 ﹤0.01% 4134
2016
Q3
$10K Hold
17,548
– – ﹤0.01% 4137
2016
Q2
$3K Buy
+17,548
New +$9.14K ﹤0.01% 4207

Northern Trust's AST.WS Position: Q3 2017 in Review

Northern Trust sold out of Asterias Biotherapeutics Warrants (AST.WS) in Q3 2017, closing a stake of 17,548 shares — an estimated $9K sold.

Northern Trust first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $10K in Q4 2016. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Northern Trust reported no remaining Asterias Biotherapeutics Warrants position as of Q3 2017 after selling out during the quarter.
  • Northern Trust sold 17,548 Asterias Biotherapeutics Warrants shares in Q3 2017, an estimated $9K.
  • Northern Trust first reported a position in Asterias Biotherapeutics Warrants in Q2 2016 and held it in 5 quarters.
  • Northern Trust's Asterias Biotherapeutics Warrants position peaked at $10K in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Warrants as of Q3 2017.

Based on Northern Trust's 13F filing for Q3 2017, filed 13 Nov 2017.